Adjuvant Capital GP, L.P.
Related Filers (4)
- AN2 Therapeutics, Inc. (14)
- Adjuvant Global Health Technology Fund, L.P. (10)
- Adjuvant Global Health Technology Fund DE, L.P. (10)
- Adjuvant Capital Management, LLC (10)
- Show More ...
Other (4)
144
Tuesday, 11/14/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 10/2/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 9/29/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/23/2023
Filing for proposed sale of securities under Rule 144
Ownership (10)
4
Thursday, 1/18/2024
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/16/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/29/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/15/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/8/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/25/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 6/24/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Friday, 6/24/2022
AN2 Therapeutics, Inc.: Initial statement of beneficial ownership of securities